rs375049839
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004260.4(RECQL4):c.2747C>T(p.Pro916Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000133 in 1,603,698 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000138 AC: 21AN: 152196Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000264 AC: 61AN: 231140Hom.: 0 AF XY: 0.000286 AC XY: 36AN XY: 125802
GnomAD4 exome AF: 0.000132 AC: 192AN: 1451502Hom.: 0 Cov.: 67 AF XY: 0.000129 AC XY: 93AN XY: 721200
GnomAD4 genome AF: 0.000138 AC: 21AN: 152196Hom.: 0 Cov.: 34 AF XY: 0.000161 AC XY: 12AN XY: 74356
ClinVar
Submissions by phenotype
not provided Uncertain:2
- -
Observed in individuals with cancer undergoing multi-gene panel testing (Mandelker et al., 2017); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 33503190, 28873162, 27535533) -
Rothmund-Thomson syndrome type 2 Uncertain:1
The RECQL4 c.2747C>T (p.Pro916Leu) missense change is absent in gnomAD v2.1.1 (https://gnomad.broadinstitute.org/). In silico tools predict a benign effect of this variant on protein function, but to our knowledge functional studies have not been performed. To our knowledge, this variant has not been reported in individuals with RECQL4-associated conditions. In summary, the evidence currently available is insufficient to determine the clinical significance of this variant. It has therefore been classified as of uncertain significance. -
Baller-Gerold syndrome Uncertain:1
This sequence change replaces proline with leucine at codon 916 of the RECQL4 protein (p.Pro916Leu). The proline residue is moderately conserved and there is a moderate physicochemical difference between proline and leucine. This variant is present in population databases (rs375049839, gnomAD 0.09%). This variant has not been reported in the literature in individuals affected with RECQL4-related conditions. ClinVar contains an entry for this variant (Variation ID: 406920). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RECQL4 protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
RECQL4-related disorder Uncertain:1
The RECQL4 c.2747C>T variant is predicted to result in the amino acid substitution p.Pro916Leu. This variant has been reported in a patient with kidney cancer and family history of breast and kidney cancer but who also carried other variants of uncertain significance in CHEK2 and POLE (LOVD; http://www.inc.gob.ar/sither/individuals/00002309). This variant is reported in 0.092% of alleles in individuals of Ashkenazi Jewish descent in gnomAD is interpreted as a variant of uncertain significance in ClinVar (https://preview.ncbi.nlm.nih.gov/clinvar/variation/406920). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at